Pioneering the Future of Virtual Neuro-Rehabilitation
Redefining Neurological Recovery in the Digital Age
In a world where neurological conditions like stroke, Parkinson’s, and multiple sclerosis continue to challenge the healthcare system, Neurofenix, under the visionary leadership of Guillem Singla Buxarrais, is changing the narrative. What started as a deeply personal mission born from a family tragedy has evolved into a global health-tech revolution—one that blends empathy, engineering, and evidence into a new standard for neuro-rehabilitation.
From its roots in the UK to a bold expansion into the United States, Neurofenix is disrupting conventional rehabilitation with AI-driven virtual care solutions. At the heart of this movement is the NeuroBall™, a patented medical device that allows patients to undergo therapy in the comfort of their homes while gamifying recovery. Alongside it stands the NeuroPlatform, a comprehensive virtual rehabilitation ecosystem that’s as scalable as it is effective.
It represents a seismic shift in how we deliver care—one that tackles health disparities, alleviates clinician shortages, and dramatically reduces costs. In doing so, it offers a lifeline to millions of patients and caregivers left behind by traditional systems.
From Engineering Lab to Global Mission
Singla Buxarrais’ journey into neuro-rehabilitation began in academia, where he earned top honours in Biomedical Engineering from the University of Barcelona and later Imperial College London. But it was a family member’s stroke in 2010 that transformed his technical pursuit into a passionate quest to humanize recovery. Disappointed by the lack of engaging rehab options, he envisioned technology that could restore both motor function and hope.
That vision led to the founding of Neurofenix in 2016, alongside co-founder Dimitris Athanasiou, who had also experienced the healthcare system’s limitations firsthand. What followed was nearly a decade of relentless innovation, including the development of the NeuroBall™—an FDA-registered, sensor-equipped device that turns repetitive rehab into engaging challenges.
Today, with over 3,000 patients treated, more than 200 care providers served, and $12 million in international funding secured, Neurofenix is no longer a promising startup. It’s a proven solution at the intersection of AI, telehealth, and human-centred design.
The Platform That’s Democratizing Rehab
Traditional neuro-rehabilitation is costly, time-consuming, and often inaccessible—especially for the 45 million Americans in rural areas. Neurofenix’s NeuroPlatform solves this with fully virtual, high-repetition therapy programs that can deliver 20x more repetitions than in-clinic sessions. These programs do not just treat stroke survivors; they now address Parkinson’s, Alzheimer’s, MS, spinal cord injuries, and traumatic brain injuries.
Even more compelling is how these digital pathways impact the real world:
- Cost Savings: With the U.S. spending over $103.5 billion annually on stroke-related care, Neurofenix’s home-based programs have the potential to save billions by reducing hospital readmissions and nursing home stays.
- Health Equity: By bypassing geographic and financial barriers, Neurofenix expands care to underserved populations, delivering on its promise of healthcare without borders.
- Caregiver Empowerment: With over 53 million Americans serving as unpaid caregivers, the platform also provides tools for monitoring, engagement, and support—relieving emotional and logistical burdens.
The results are unmistakable: improved mobility, higher therapy adherence, lower costs, and—most importantly—renewed independence for thousands of individuals.
Beyond Technology: A Vision for the Future
Singla Buxarrais isn’t stopping with current success. His 3–7 years roadmap includes launching AI-powered predictive models, developing personalized neuro-avatars, and expanding into value-based care collaborations with CMS and top U.S. institutions like NYU Langone, Emory, and Johns Hopkins.
He is also setting his sights on the bigger picture—expanding Neurofenix’s reach to cover the top 25 neurological conditions, then transitioning to support other chronic care needs such as COPD, cardiac recovery, and MSK disorders. The long-term ambition? To establish the world’s most comprehensive virtual rehabilitation platform—a one-stop solution for recovery across the continuum of care.
Powering the U.S. Economy While Healing It
As Neurofenix scales across the U.S., it’s doing more than healing patients—it’s stimulating the economy. The company is actively:
- Localizing manufacturing, creating jobs in engineering and logistics
- Collaborating with academic and health institutions to advance clinical trials and AI research
- Contributing to national public health goals, including CMS’s 2030 vision for universal value-based care
From Atlanta to Florida and beyond, the company is poised to create thousands of high-skill jobs while solidifying America’s leadership in digital healthcare.
A Mission Rooted in Empathy and Evidence
Despite the cutting-edge technology, what sets Neurofenix apart is its soul. Every product is co-designed with input from patients, caregivers, and clinicians. Every program is validated by evidence and optimized for real-world results. And every step forward is informed by the stories of people like Singla Buxarrais’ own family—individuals whose lives could have been radically different with the right tools and support.
In a healthcare landscape grappling with inefficiencies and inequities, Neurofenix offers not just a solution but a paradigm shift. It embodies the belief that recovery should be personal, accessible, and empowering—not just for the few, but for everyone.
As Singla Buxarrais puts it, “Recovery should never depend on your zip code, income level, or the number of therapists in your area. It should depend on science, data, and determination—and that’s what we deliver.”
In the years ahead, as the world rethinks what post-acute care looks like, one thing is clear: Neurofenix is not just part of the future of rehabilitation—it’s leading it.
“Redefining recovery through AI-powered therapy that begins at home”
“From stroke to strength — revolutionizing neuro care for every patient, everywhere”
Company Name : Neurofenix
Website : https://www.neurofenix.com
Management Team
Guillem Singla Buxarrais | Co-Founder &
CEO
